[2-(1-methylpyrazol-4-yl)-6-morpholin-4-yl-7H-purin-8-yl]-(4-phenylpiperazin-1-yl)methanone
C24H27N9O2 — CID 122589764
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-(1-methylpyrazol-4-yl)-6-morpholin-4-yl-7H-purin-8-yl]-(4-phenylpiperazin-1-yl)methanone
[2-(1-methylpyrazol-4-yl)-6-morpholin-4-yl-7H-purin-8-yl]-(4-phenylpiperazin-1-yl)methanone (PubChem CID 122589764) has the molecular formula C24H27N9O2 and a molecular weight of 473.54 g/mol. Its IUPAC name is [2-(1-methylpyrazol-4-yl)-6-morpholin-4-yl-7H-purin-8-yl]-(4-phenylpiperazin-1-yl)methanone.
Molecular Properties
| Compound Name | [2-(1-methylpyrazol-4-yl)-6-morpholin-4-yl-7H-purin-8-yl]-(4-phenylpiperazin-1-yl)methanone |
|---|---|
| PubChem CID | 122589764 |
| Molecular Formula | C24H27N9O2 |
| Molecular Weight | 473.54 g/mol |
| Exact Mass | 473.23 |
| IUPAC Name | [2-(1-methylpyrazol-4-yl)-6-morpholin-4-yl-7H-purin-8-yl]-(4-phenylpiperazin-1-yl)methanone |
| SMILES | Cn1cc(-c2nc(N3CCOCC3)c3[nH]c(C(=O)N4CCN(c5ccccc5)CC4)nc3n2)cn1 |
| InChI | InChI=1S/C24H27N9O2/c1-30-16-17(15-25-30)20-27-21-19(23(29-20)32-11-13-35-14-12-32)26-22(28-21)24(34)33-9-7-31(8-10-33)18-5-3-2-4-6-18/h2-6,15-16H,7-14H2,1H3,(H,26,27,28,29) |
| InChIKey | FRACBBVJYOXGOC-UHFFFAOYSA-N |
| XLogP | 1.55 |
| TPSA | 108.30 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 473.54 |
| LogP ≤ 5 | 1.55 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122589764 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.